The increasing prevalence of hypertension and cardiovascular diseases is expected to drive the growth of the sphygmomanometer market. Growing awareness about the importance of monitoring blood pressure regularly is also contributing to the market growth. Furthermore, the rising geriatric population and the increasing adoption of telehealth services are creating opportunities for market expansion.
Industry
Report Coverage | Details |
---|---|
Segments Covered | Product, Operation, Configuration, End User |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | A & D Company, Welch Allyn, Koninklijke Philips N.V., General Electric, Omron, Beurer, Paul Hartmann AG, Microlife, American Diagnostic, Rossmax International |
The high cost associated with advanced sphygmomanometers is a major restraint for market growth. Limited access to healthcare facilities, especially in developing regions, is also hindering the market growth. Additionally, the presence of alternative blood pressure monitoring devices, such as wearable technology, is posing a challenge to the sphygmomanometer market.